Telos Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,347
Closed -$345K 195
2022
Q4
$345K Sell
12,347
-23
-0.2% -$588 0.05% 146
2022
Q3
$289K Sell
12,370
-1,194
-9% -$36K 0.05% 147
2022
Q2
$458K Sell
13,564
-190
-1% -$6.66K 0.07% 133
2022
Q1
$480K Sell
13,754
-296
-2% -$10.1K 0.06% 137
2021
Q4
$428K Sell
14,050
-327
-2% -$10.7K 0.05% 137
2021
Q3
$471K Sell
14,377
-2,764
-16% -$88.4K 0.06% 133
2021
Q2
$519K Buy
+17,141
New +$564K 0.07% 132

Other funds holding OGN

Telos Capital Management's OGN Position: Q1 2023 in Review

Telos Capital Management sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 12,347 shares — an estimated $345K sold.

Telos Capital Management first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $519K in Q2 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Telos Capital Management reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Telos Capital Management sold 12,347 Organon & Co shares in Q1 2023, an estimated $345K.
  • Telos Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Telos Capital Management's Organon & Co position peaked at $519K in Q2 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Telos Capital Management's 13F filing for Q1 2023, filed 27 Apr 2023.